308,309 EMT, CSCs, and DTPs are interconnected via regulatory networks involving transcription factors (e.g., SNAIL, ZEB1), 318 signaling cascades (e.g., TGF-), and cues from the TME (e.g., CAFs, hypoxia), collectively sustaining tumor heterogeneity and adaptive resistance
What has been reported in the available human pilot research is that no significant adverse effects were observed - which is a meaningful data point for safety consideration, even if it does not establish efficacy by clinical standards
Global Peptide Therapy Market Statistics Global peptide therapy market value (2025): USD 84.2 billion CAGR 14.74% (20262031) USD 196.5 billion by 2031 Global peptide therapy volume (2025): 20.2 billion dosage units volume CAGR 21.24% 65.5 billion units by 2031
For patients frustrated by persistent pain and limited treatment options, therapies like BPC-157 offer hope for healing at a deeper, cellular level